These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12729829)

  • 1. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones.
    Manetti F; Forli S; Maccari L; Corelli F; Botta M
    Farmaco; 2003 May; 58(5):357-61. PubMed ID: 12729829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.
    Manetti F; Maccari L; Corelli F; Botta M
    Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones.
    Forli S; Manetti F; Altmann KH; Botta M
    ChemMedChem; 2010 Jan; 5(1):35-40. PubMed ID: 19904799
    [No Abstract]   [Full Text] [Related]  

  • 4. 3D QSAR studies for the beta-tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs): a pseudoreceptor model for taxanes based on the experimental structure of tubulin.
    Maccari L; Manetti F; Corelli F; Botta M
    Farmaco; 2003 Sep; 58(9):659-68. PubMed ID: 13679158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
    Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
    Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative molecular field analysis (coMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods.
    Lee KW; Briggs JM
    J Comput Aided Mol Des; 2001 Jan; 15(1):41-55. PubMed ID: 11217918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents.
    Fojo T; Menefee M
    Ann Oncol; 2007 Jul; 18 Suppl 5():v3-8. PubMed ID: 17656560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the activity of the microtubule-stabilizing agent epothilone a studied by NMR spectroscopy in solution.
    Reese M; Sánchez-Pedregal VM; Kubicek K; Meiler J; Blommers MJ; Griesinger C; Carlomagno T
    Angew Chem Int Ed Engl; 2007; 46(11):1864-8. PubMed ID: 17274084
    [No Abstract]   [Full Text] [Related]  

  • 10. Microtubules: an overview.
    Wade RH
    Methods Mol Med; 2007; 137():1-16. PubMed ID: 18085218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.
    Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y
    Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoMFA, HQSAR and molecular docking studies of butitaxel analogues with beta-tubulin.
    Cunningham SL; Cunningham AR; Day BW
    J Mol Model; 2005 Feb; 11(1):48-54. PubMed ID: 15616834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity-based virtual screening for microtubule stabilizers reveals novel antimitotic scaffold.
    Ayoub AT; Klobukowski M; Tuszynski J
    J Mol Graph Model; 2013 Jul; 44():188-96. PubMed ID: 23871820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
    Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
    Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular recognition of epothilones by microtubules and tubulin dimers revealed by biochemical and NMR approaches.
    Canales A; Nieto L; Rodríguez-Salarichs J; Sánchez-Murcia PA; Coderch C; Cortés-Cabrera A; Paterson I; Carlomagno T; Gago F; Andreu JM; Altmann KH; Jiménez-Barbero J; Díaz JF
    ACS Chem Biol; 2014 Apr; 9(4):1033-43. PubMed ID: 24524625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.
    Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF
    Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling.
    Entwistle RA; Rizk RS; Cheng DM; Lushington GH; Himes RH; Gupta ML
    ChemMedChem; 2012 Sep; 7(9):1580-6. PubMed ID: 22807375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and mutated tubulin complexes with epothilone B.
    Navarrete KR; Alderete JB; Jiménez VA
    J Biomol Struct Dyn; 2015; 33(12):2530-40. PubMed ID: 26081685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding tubulin/microtubule-taxane interactions: a quantitative structure-activity relationship study.
    Hansch C; Verma RP
    Mol Pharm; 2008; 5(1):151-61. PubMed ID: 18171015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drugs targeting microtubules: the role of epothilones.
    Ferrandina G; Mariani M; Andreoli M; Shahabi S; Scambia G; Ferlini C
    Curr Pharm Des; 2012; 18(19):2793-803. PubMed ID: 22390763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.